11A
IBB icon

10-15 Associates’s iShares Biotechnology ETF IBB Stock Holding History

10-15 Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$759K Sell
5,606
-883
-14% -$120K 0.15% 70
2020
Q2 		$887K Sell
6,489
-64
-1% -$8.16K 0.18% 65
2020
Q1 		$706K Sell
6,553
-656
-9% -$75.5K 0.16% 67
2019
Q4 		$869K Sell
7,209
-825
-10% -$92K 0.16% 73
2019
Q3 		$799K Sell
8,034
-10,265
-56% -$1.07M 0.16% 73
2019
Q2 		$2M Sell
18,299
-575
-3% -$61.2K 0.43% 51
2019
Q1 		$2.11M Buy
18,874
+84
+0.4% +$9.21K 0.45% 50
2018
Q4 		$1.81M Sell
18,790
-175
-0.9% -$18.6K 0.44% 48
2018
Q3 		$2.31M Sell
18,965
-7,021
-27% -$827K 0.52% 47
2018
Q2 		$2.85M Buy
25,986
+1,800
+7% +$193K 0.64% 41
2018
Q1 		$2.58M Buy
24,186
+1,095
+5% +$121K 0.61% 41
2017
Q4 		$2.46M Buy
23,091
+126
+0.5% +$13.5K 0.59% 42
2017
Q3 		$2.55M Sell
22,965
-219
-0.9% -$23.4K 0.64% 38
2017
Q2 		$2.4M Sell
23,184
-198
-0.8% -$19.5K 0.67% 37
2017
Q1 		$2.29M Buy
23,382
+2,988
+15% +$286K 0.63% 41
2016
Q4 		$1.8M Sell
20,394
-3,813
-16% -$347K 0.51% 52
2016
Q3 		$2.34M Sell
24,207
-192
-0.8% -$18.3K 0.65% 42
2016
Q2 		$2.09M Buy
24,399
+7,209
+42% +$647K 0.6% 46
2016
Q1 		$1.49M Sell
17,190
-3,057
-15% -$273K 0.46% 52
2015
Q4 		$2.28M Buy
20,247
+1,014
+5% +$110K 0.66% 45
2015
Q3 		$1.94M Sell
19,233
-405
-2% -$48.6K 0.67% 40
2015
Q2 		$2.42M Buy
19,638
+1,917
+11% +$229K 0.75% 38
2015
Q1 		$2.03M Sell
17,721
-720
-4% -$79.4K 0.68% 39
2014
Q4 		$1.86M Sell
18,441
-537
-3% -$52.2K 0.6% 44
2014
Q3 		$1.73M Buy
18,978
+549
+3% +$48.2K 0.58% 45
2014
Q2 		$1.58M Hold
18,429
– – 0.5% 46
2014
Q1 		$1.45M Sell
18,429
-19,260
-51% -$1.6M 0.47% 47
2013
Q4 		$2.85M Sell
37,689
-153
-0.4% -$10.9K 0.98% 29
2013
Q3 		$2.64M Sell
37,842
-423
-1% -$27.7K 1.1% 27
2013
Q2 		$2.22M Buy
+38,265
New +$2.21M 1.02% 27

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

10-15 Associates's IBB Position: Q3 2020 in Review

10-15 Associates reduced its iShares Biotechnology ETF (IBB) stake by 14% in Q3 2020, selling an estimated $120K and leaving 5,606 shares worth $759K. The position accounts for 0.15% of the portfolio, ranked #70.

10-15 Associates first reported a position in IBB in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.85M in Q2 2018. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

  • 10-15 Associates held 5,606 shares of iShares Biotechnology ETF worth $759K as of Q3 2020.
  • 10-15 Associates sold 883 iShares Biotechnology ETF shares in Q3 2020, an estimated $120K.
  • iShares Biotechnology ETF made up 0.15% of 10-15 Associates's portfolio in Q3 2020, its #70 holding.
  • 10-15 Associates first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 30 quarters since.
  • 10-15 Associates's iShares Biotechnology ETF position peaked at $2.85M in Q2 2018.
  • 784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.